the J-pouch for an average of 7.6 ± 4.7 years aft er IPAA. A total of 7 patients (63.7%) were found to have CD of the pouch based on the presence of perianal fi stulas, ileitis with strictures, or granulomas. In these patients, the number of years from the time of IPAA to the development of CD was 5.0 ± 4.9 years. Th e pouch outcomes were compared with the control group (Table) . Conclusion: Postoperative recurrence of CD of the pouch was common in patients with a preoperative diagnosis of CD who underwent IPAA. Th e patients oft en required long term medical therapy. However, the majority of patients could still keep the pouch for a prolonged time period.
Purpose: It is understood that drug delivery is a key component of eff ective induction and maintenance of remission in UC. Previous work has documented variations in gut pH of patients and healthy volunteers, and it has been postulated that these variations may aff ect successful treatment. We previously measured the total gut pH in 10 patients with mildly to moderately active UC and found that the pH in the colon was more acidic than described in a separate study of healthy volunteers.(1,2) We have followed two of these patients over time in order to understand how colonic pH varies with disease activity. Methods: Two patients with endoscopic, histologic and clinical diagnoses of long-standing UC were recruited while their disease was active, and then followed until they achieved clinical remission. During the active and remitted phases, they underwent total gut pH, pressure, and temperature measurements with SmartPill pH, a device for gastroparesis but previously used by us in the UC population.(1) Acid blocking therapies were prohibited and a standardized diet was employed for these studies. Gut transit was calculated based on validated changes in pressure and pH. Results: Patient 1 is a 39 yo ex-smoking male with left -sided colitis diagnosed 12 years ago, and maintained on delayed-release mesalamine 4.8 g/d. He had clinically mild relapse symptoms of urgency and hematochezia (SCCAI=2). He was treated with corticosteroids, successfully achieving clinical remission (SCCAI=0), and was maintained with the same 5-ASA. Patient 2 is a 29 yo ex-smoking male with pancolitis diagnosed 8 years ago, and had been maintained with delayed-release mesalamine 4.8 g/d and azathioprine (2.5 mg/kg/ d). He had clinically mild relapse (SCCAI=3) confi rmed by colonoscopy. He was treated with corticosteroids to achieve remission (SCCAI=0) and then maintained on the same 5-ASA and azathioprine therapies. Th e remission measurements were obtained aft er 7 months of stable disease in patient 1 and 8 months of stable disease in patient 2. Th eir pH measurements are presented in the Table. Conclusion: Th is is the fi rst known report of pH measurements in the same UC patients with active infl ammation and subsequent clinical remission. In these two patients with long-standing UC, the colonic pH rose substantially between active infl ammation and subsequent clinical quiescence. Th ese observations may have implications for therapy, and modifi cations of delivery systems during diff erent phases of this condition. Further study is needed Purpose: Th iopurine methyltransferase (TPMT) metabolizes azathioprine (AZA) and mercaptopurine (6MP) into active and inactive metabolites. Optimal therapeutic eff ect is achieved at 6-thioguanine levels (6TG) between 230-400. Achieving therapeutic levels of 6TG is limited by the concurrent production of the inactive hepatotoxic metabolite 6-methylmercaptopurine (6MMP). A patient's TPMT enzyme activity is related to the ratio of production of these metabolites. Table 2) . Age at surgery, active smoking, or use of estrogens did not infl uence development of VTE. Only 1 of 8 patients developed a pelvic abscess (a risk factor for VTE). Only 3/8 had a coagulation profi le obtained which was negative in each case. All patients received low dose heparin and TED stockings with STD rollers to prevent VTE postoperatively. Conclusion: Patients with IBD who undergo surgery are at increased risk for VTE. Th e risk is signifi cantly greater in CD patients who require proctectomy, with a trend suggesting the risk is even greater in CD than in UC if proctectomy is performed. 
